Status:
UNKNOWN
Anxiety Related to the Diagnosis of Alzheimer's Disease or Related Diseases
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cognitive Decline
Eligibility:
All Genders
55+ years
Brief Summary
Improving the diagnosis of neurocognitive disorders is a major public health challenge. This diagnosis occurs too late in the majority of cases, or is even sometimes non-existent for some despite the ...
Detailed Description
Improving the diagnosis of neurocognitive disorders is a major public health challenge. This diagnosis occurs too late in the majority of cases, or is even sometimes non-existent for some despite the ...
Eligibility Criteria
Inclusion
- Patients :
- Man or woman 55 years and over
- Patient received for the first time in Memory Consultation and not aware of his diagnosis
- Patient with a Mini-Mental State Assessment score (MMSE) ≥ 20
- Patient accompanied by a primary caregiver
- Patient able to provide consent to participate in research
- Caregiver:
- The caregiver accompanies the patient and is considered as the main caregiver during the consultation
- is able to provide consent to participate in research
Exclusion
- Patient living in a care homes
- Patient protected by law (under legal protection, guardianship or trusteeship)
- Patient with a hearing or visual impairment that does not allow to carry out assessments in Memory Consultation
- Patient opposing research
Key Trial Info
Start Date :
May 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04342520
Start Date
May 16 2022
End Date
June 1 2023
Last Update
January 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital des Charpennes (HCL)
Lyon, France, 69100